Add objective developmental data alongside your VB-MAPP assessments.
The VB-MAPP tells you which social skills a child has. EarliPoint tells you how they’re engaging with the social world, before those skills show up. That’s the layer you need to teach the foundations that complex social learning is built on.
Together, they give your clinicians different types of information to consider when understanding a child’s development and progress over time.
Schedule a Demo & Walkthrough
Fill out the form to receive a sample report and see how ABA providers are using it in their workflow.
How EarliPoint Complements the VB-MAPP
Different measures. Different insights.
The VB-MAPP gives clinicians valuable information about a child’s language, learning, social skills, and barriers to progress. It helps your team understand current skills and make informed decisions about treatment priorities. EarliPoint measures something different.
During a quick, child-friendly session, eye-tracking technology measures social visual engagement directly and consistently. The results provide objective developmental data that qualified clinicians can interpret alongside the VB-MAPP and the other information they already use. EarliPoint doesn’t replace the VB-MAPP or change its role in your practice. It adds another source of information that can help your team understand development and change over time.
| Area | VB-MAPP | EarliPoint (Objective Layer) |
|---|---|---|
| What It Measures | Language, learning, and social skills against developmental milestones | Objective indices of social attention, verbal, and nonverbal development via eye-tracking |
| Method | Clinician observation + criterion-referenced scoring | Automated eye-tracking biomarker, observer-independent |
| Output | Skill milestones, barriers, placement guidance | Quantitative indices, trackable over time |
| Strength | Tells you what to teach next | Tells you how development is changing, in numbers that don't depend on who measured them |
| Administration | By a BCBA | By trained staff |
Proven Science
Decades of research. Breakthrough results.
EarliPoint is backed by more than 20 years of research into autism and social visual engagement.
The EarliPoint System is an FDA-cleared medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder. Its research foundation includes large-scale clinical studies, peer-reviewed publications, and academic research conducted in collaboration with leading institutions.
Our research foundation includes:
-
Clinical Validation — Two large-scale, double-blind clinical studies
-
Peer Review — Findings published in the Journal of the American Medical Association (JAMA)
-
Academic Excellence — Research conducted in collaboration with Yale University and Emory University
DATE: September 5, 2023
Eye-Tracking-Based Measurement of Social Visual Engagement Compared with Expert Clinical Diagnosis of Autism.
DATE: September 5, 2023
Development and Replication of Objective Measurements of Social Visual Engagement to Aid in Early Diagnosis and Assessment of Autism.
Common Questions
No, and it isn’t designed to. VB-MAPP drives curriculum and IEP goals. EarliPoint adds an objective developmental data stream beside it. It complements, and never replaces, clinical judgment and established assessment practices.
Trained staff administer the quick assessment; qualified clinicians interpret results. It doesn’t add BCBA hours; it gives them back.
Many payers increasingly look for standardized, objective outcome data alongside criterion-referenced tools like VB-MAPP. An observer-independent measure repeated on your reassessment cadence strengthens the clinical picture you present. Coverage decisions always rest with the payer.
EarliPoint is FDA-cleared for children 16 through 95 months who are at risk based on concerns from a parent, caregiver, or healthcare provider — a range that overlaps VB-MAPP’s early-learner window and extends beyond it.
Keep the VB-MAPP. Add Another Perspective.
See how EarliPoint can work alongside the assessments your team already uses and fit into your existing reassessment workflow.
